Search

everythinglearnresearchcommunity

for

Search:↓

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Taking Propecia might lead to the development of cataracts.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

People with Mucopolysaccharidoses often have skin problems like thick skin and extra hair, and recognizing these can help diagnose and treat the condition early.

Finasteride, often used for hair loss, can potentially cause cataracts.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.